Humasis has ranked among the top searched stocks for 8 days in the past month.

As of 10:32 AM on the 20th, Humasis is trading at 3,775 KRW, up 13.02% from the previous day. This represents a 65.21% increase compared to April 17. Humasis is known as a company specializing in in vitro diagnostic devices.

Today, foreigners have sold a net 27,000 shares of Humasis, while institutions have bought a net 92,000 shares, according to provisional data. Over the past 5 days, individual investors have bought a net 916,668 shares, foreigners have bought a net 40,982 shares, and institutions have sold a net 911,257 shares.

On May 14, Humasis was a market topic with a 12% rise due to the increase in COVID-19 diagnostic kit stocks.



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing